Company / Profit Margin
Xenon Pharmaceuticals Inc. Profit Margin History
FY2016-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-101.1%
FY2017
5-year range
-
FY2016-FY2017
Trend
+92.1%
vs FY2016
Sector context
#97 of 146
Health Care
What the data says
At -101.1%, Xenon Pharmaceuticals Inc.'s profit margin ranks #97 of 146 in the Health Care sector.
Based on SEC 10-K filings.
-101.1% in FY2017.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
#97 of 146 in Health CareTop 66% of 146This company -101.1% Sector average -796.3%
▼
+87.3% above sector average
Key checks
Key Insights
- In FY2017, profit margin increased 92.1% year-over-year.
- Currently 695.2pp above the Health Care sector average.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.51 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | -101.1% | +92.1% |
| FY2016 | -1275.5% | -1161.4% |
As of FY2017 · SEC 10-K · Updated Jun 30, 2026